Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruzinurad and Febuxostat in Hyperuricemia
NCT04180982Phase 2Unknown
- Sponsor
- Hengrui
- Start
- Dec 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ruzinurad in hyperuricemia, sponsored by Hengrui. Status: unknown.
02
Drugs
ruzinurad
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on NCT04180982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04180982.